SCHEMBL2495589

SCHEMBL2495589

[c]1cccc2c(OCc3ccccc3)cccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PLAU P00749 1/20 0.44
PLAT P00750 1/20 0.44
HTR1A P08908 1/20 0.44
DRD2 P14416 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.43
SRD5A2 P31213 1/20 0.43
LIPE Q05469 1/20 0.42
LTA4H P09960 2/20 0.42
PLA2G2A P14555 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
MAPK14 Q16539 1/20 0.41
F2 P00734 2/20 0.41
F9 P00740 1/20 0.41
F10 P00742 1/20 0.41
ALPG P10696 1/20 0.41
PTK2B Q14289 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5934194 0.90 MAPT (0.44) MAPTL3MBTL1MAPK1TDP1PLAU
SCHEMBL2232272 0.78 CYP2A6 (0.41) MAPTL3MBTL1TDP1ALDH1A1GAA
SCHEMBL1190605 0.76 MAPT (0.52) MAPTL3MBTL1MAPK1TDP1HTR1A
SCHEMBL29568609 0.75 MRGPRX4 (0.67) MAPTL3MBTL1MAPK1TDP1HTR1A
SCHEMBL27629 0.75 MRGPRX4 (0.67) MAPTL3MBTL1MAPK1TDP1HTR1A
SCHEMBL29115293 0.75 IDO1 (0.47) MAPTTDP1NPC1RAB9AALDH1A1
SCHEMBL6050120 0.75 CYP2A6 (0.44)
SCHEMBL510440 0.75 MAPT (0.50) MAPTL3MBTL1MAPK1TDP1PLAU
SCHEMBL7293597 0.75 MAPT (0.59) MAPTL3MBTL1MAPK1TDP1HTR1A
SCHEMBL2168004 0.75 DPP4 (0.41) MAPTL3MBTL1MAPK1HTR1ALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed
EP-1070703-A1 Cyclobutene derivatives Sankyo Company Limited (JP) 2001-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 MAPT 672/4885L3MBTL1 2814/4885MAPK1 1763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.